chr13:28577411:> Detail (hg19) (FLT3)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr13:28,577,411-28,674,713 |
| hg38 | chr13:28,003,274-28,100,576 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
| 0.005 | Chromosome Aberrations | NA | GAD | Detail | |
| 0.002 | Congenital chromosomal disease | NA | BeFree | Detail | |
| <0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| <0.001 | dermatitis | In this study, we show for the first time a significant accumulation of FLT3(+) ... | BeFree | 24895100 | Detail |
| <0.001 | Diabetes | NA | BeFree | Detail | |
| <0.001 | diabetes mellitus | NA | BeFree | Detail | |
| 0.005 | Down syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Eosinophilia | NA | BeFree | Detail | |
| <0.001 | Glioma | NA | BeFree | Detail | |
| <0.001 | Graft-vs-Host Disease | In a Cox-model of predefined variables, age, FLT3-ITD and >1 course of chemother... | BeFree | 26351297 | Detail |
| <0.001 | Hematological Disease | NA | BeFree | Detail | |
| <0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
| <0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
| 0.093 | leukemia | In contrast, neither NUP98-NSD1 nor FLT3-ITD single transduced cells were able t... | BeFree,GAD,LHGDN | 24951466 | Detail |
| 0.093 | leukemia | Targeting FLT3 to treat leukemia. | BeFree,GAD,LHGDN | 25231999 | Detail |
| 0.093 | leukemia | FLT3 was consequently upregulated in MLL-AF9-expressing immortalized and leukemi... | BeFree,GAD,LHGDN | 25234168 | Detail |
| 0.093 | leukemia | Targeting mitochondrial metabolism as an adjuvant therapy could therefore improv... | BeFree,GAD,LHGDN | 25547679 | Detail |
| 0.093 | leukemia | RNA interference against FLT3-ITD reduced cytotoxic effect and apoptosis induced... | BeFree,GAD,LHGDN | 25896848 | Detail |
| 0.093 | leukemia | The influence of genotypes on relapse, non-relapse mortality, leukemia-free surv... | BeFree,GAD,LHGDN | 26351297 | Detail |
| <0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | hairy cell leukemia | NA | BeFree | Detail | |
| 0.003 | lymphoid leukemia | NA | BeFree,GAD | Detail | |
| 0.130 | Acute lymphocytic leukemia | Our previous data demonstrated specific up-regulation of miR-155 in FLT3-ITD+ AM... | BeFree,CLINVAR | 26055960 | Detail |
| 0.002 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
| 0.120 | acute biphenotypic leukemia | NA | ORPHANET | Detail | |
| 0.001 | acute monocytic leukemia | NA | BeFree | Detail | |
| 0.057 | myeloid leukemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.008 | Myeloid Leukemia, Chronic | NA | BeFree,GAD | Detail | |
| 0.006 | Leukemia, Myelomonocytic, Chronic | NA | BeFree,GAD | Detail | |
| <0.001 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
| 0.147 | acute promyelocytic leukemia | Internal tandem duplications (ITD) of FLT3 gene occur in about a third of acute ... | BeFree,CTD_human,GAD,LHGDN | 25530565 | Detail |
| 0.003 | Leukocytosis | NA | LHGDN | Detail | |
| <0.001 | leukopenia | NA | BeFree | Detail | |
| <0.001 | lymphoma | NA | BeFree | Detail | |
| 0.002 | Lymphoproliferative Disorders | NA | GAD | Detail | |
| <0.001 | Monosomy | Some patient groups with unfavorable alterations, such as FMS-related tyrosine k... | BeFree | 24927407 | Detail |
| <0.001 | Myelodysplasia | NA | BeFree | Detail | |
| <0.001 | Acute Myeloid Leukemia, M1 | NA | BeFree | Detail | |
| 0.004 | Myeloproliferative disease | Oncogenic mutations of FLT3 and KIT receptors are associated with poor survival ... | BeFree | 25456130 | Detail |
| <0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| <0.001 | Neoplasms, Experimental | NA | BeFree | Detail | |
| 0.002 | Pathologic Neovascularization | NA | GAD | Detail | |
| 0.002 | nephroblastoma | NA | BeFree | Detail | |
| 0.001 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | obesity | NA | BeFree | Detail | |
| 0.002 | osteoporosis | NA | GAD | Detail | |
| 0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
| <0.001 | paraplegia | We herein report a case of AML accompanied by thoracic epidural MS with a high C... | BeFree | 24881741 | Detail |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| 0.012 | Preleukemia | NA | BeFree,GAD | Detail | |
| <0.001 | psoriasis | These findings show that targeted inhibition of FLT3, and hence direct interfere... | BeFree | 24895100 | Detail |
| <0.001 | Dermatologic disorders | NA | BeFree | Detail | |
| 0.120 | thrombosis | NA | CTD_human | Detail | |
| 0.002 | Tobacco use disorder | NA | GAD | Detail | |
| 0.002 | Chromosomal translocation | NA | GAD | Detail | |
| 0.002 | XYY Karyotype | NA | GAD | Detail | |
| 0.011 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | Patau syndrome | NA | BeFree | Detail | |
| <0.001 | Granulocytic Sarcoma | NA | BeFree | Detail | |
| <0.001 | Germ cell tumor | Next generation sequencing analysis of platinum refractory advanced germ cell tu... | BeFree | 25085632 | Detail |
| <0.001 | Neuroectodermal Tumors | NA | BeFree | Detail | |
| <0.001 | Neuroectodermal Tumor, Primitive | NA | BeFree | Detail | |
| 0.007 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
| 0.008 | pediatric acute myeloblastic leukemia | FLT3/ITD is associated with poor outcomes in adult and pediatric acute myeloid l... | BeFree | 25662999 | Detail |
| <0.001 | Mastocytosis, Systemic | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| 0.012 | Neoplasm, Residual | We report the application of a new technique, tandem duplication PCR (TD-PCR), f... | BeFree,GAD,LHGDN | 25240816 | Detail |
| 0.012 | Neoplasm, Residual | Although pretreatment covariates such as cytogenetics, monosomal karyotype, rela... | BeFree,GAD,LHGDN | 25732155 | Detail |
| <0.001 | Miller Dieker syndrome | NA | BeFree | Detail | |
| <0.001 | Trisomy 22 | NA | BeFree | Detail | |
| <0.001 | relapsing chronic myelogenous leukemia | NA | BeFree | Detail | |
| <0.001 | T-cell adult acute lymphoblastic leukemia | NA | BeFree | Detail | |
| <0.001 | childhood acute promyelocytic leukemia (M3) | NA | BeFree | Detail | |
| <0.001 | extraosseous Ewings sarcoma-primitive neuroepithelial tumor | NA | BeFree | Detail | |
| <0.001 | Refractory anemia with excess blasts in transformation (clinical) | NA | BeFree | Detail | |
| <0.001 | Acute Undifferentiated Leukemia | SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug ... | BeFree | 25280219 | Detail |
| 0.002 | secondary acute myeloid leukemia | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| 0.081 | juvenile myelomonocytic leukemia | NA | BeFree,MGD | Detail | |
| <0.001 | Sarcoma of breast | NA | BeFree | Detail | |
| 0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
| 0.005 | Hematologic Neoplasms | NA | BeFree,LHGDN | Detail | |
| <0.001 | Trisomy 11 | NA | BeFree | Detail | |
| <0.001 | Chromosome 8, trisomy | We aimed to examine the consequences of targeting MYC both directly and indirect... | BeFree | 25956709 | Detail |
| <0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Ewings sarcoma | NA | BeFree | Detail | |
| <0.001 | Hypofibrinogenemia | NA | BeFree | Detail | |
| 0.009 | Leukemogenesis | NA | BeFree | Detail | |
| <0.001 | Lymphoid neoplasm | NA | BeFree | Detail | |
| 0.560 | Leukemia, Myelocytic, Acute | Among five patients diagnosed with MDS/MPN-U, three patients harboured RUNX1 (AM... | BeFree | 22571758 | Detail |
| 0.001 | Refractory cancer | NA | BeFree | Detail | |
| <0.001 | polycythemia vera | JAK2(V617F) and FLT3(ITD)-positive polycythemia vera cells and acute myeloid leu... | BeFree | 22411871 | Detail |
| 0.560 | Leukemia, Myelocytic, Acute | JAK2(V617F) and FLT3(ITD)-positive polycythemia vera cells and acute myeloid leu... | BeFree | 22411871 | Detail |
| 0.006 | Leukemia, Myelomonocytic, Chronic | At the time of MDS to CMML evolution, mutations in JAK2 (V617F), FLT3 (ITD), K-r... | BeFree | 17050076 | Detail |
| 0.008 | Myeloid Leukemia, Chronic | Previous studies have reported FLT3 mutation in as many as 9.2% of myeloprolifer... | BeFree | 23846442 | Detail |
| <0.001 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | NA | BeFree | Detail | |
| 0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Hypereosinophilia | NA | BeFree | Detail | |
| <0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Myelosuppression | Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted a... | BeFree | 25531068 | Detail |
| <0.001 | Rhabdoid Tumor of the Kidney | NA | BeFree | Detail | |
| 0.080 | Arthritis, Experimental | NA | RGD | Detail | |
| <0.001 | Neutrophilic dermatosis | NA | BeFree | Detail | |
| <0.001 | sarcoma | NA | BeFree | Detail | |
| 0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| 0.001 | Chronic myeloproliferative disorder | Oncogenic mutations of FLT3 and KIT receptors are associated with poor survival ... | BeFree | 25456130 | Detail |
| <0.001 | Therapy-related myelodysplastic syndrome | TP53 was the most common mutated gene in t-MDS (35.7%) as well as t-AML (33.3%),... | BeFree | 25573287 | Detail |
| <0.001 | Mast cell malignancy | NA | BeFree | Detail | |
| <0.001 | Eosinophilic disorder | NA | BeFree | Detail | |
| <0.001 | M5b Acute differentiated monocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | NA | BeFree | Detail | |
| <0.001 | Treatment related acute myeloid leukaemia | NA | BeFree | Detail | |
| <0.001 | Undifferentiated leukemia | SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug ... | BeFree | 25280219 | Detail |
| <0.001 | Mammary Neoplasms | NA | BeFree | Detail | |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| <0.001 | colorectal cancer | NA | BeFree | Detail | |
| <0.001 | Chronic myeloid leukemia in lymphoid blast crisis | NA | BeFree | Detail | |
| <0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
| <0.001 | Disorder characterized by eosinophilia | NA | BeFree | Detail | |
| 0.003 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | We report the application of a new technique, tandem duplication PCR (TD-PCR), f... | BeFree | 25240816 | Detail |
| <0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
| 0.034 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Our previous data demonstrated specific up-regulation of miR-155 in FLT3-ITD+ AM... | BeFree,GAD,LHGDN | 26055960 | Detail |
| <0.001 | Leukemia, B-Cell | NA | BeFree | Detail | |
| <0.001 | Extramedullary Hematopoiesis (disorder) | NA | BeFree | Detail | |
| 0.001 | Hyperdiploid B Acute Lymphoblastic Leukemia | We examined three pairs of monozygotic twins, two concordant and one discordant ... | BeFree | 24897505 | Detail |
| <0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | acute myeloid leukemia with myelodysplasia-related changes | NA | BeFree | Detail | |
| <0.001 | Treatment related leukaemia | NA | BeFree | Detail | |
| <0.001 | acute myeloid leukemia with mutated CEBPA | Our data confirm that dmCEBPA but not smCEBPA is prognostically favorable in NPM... | BeFree | 25400766 | Detail |
| <0.001 | Neural crest tumor | NA | BeFree | Detail | |
| <0.001 | Refractory anemia, without ringed sideroblasts, without excess blasts | NA | BeFree | Detail | |
| 0.027 | myelodysplastic syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Intracranial glioma | NA | BeFree | Detail | |
| 0.120 | Leukemia, acute lymphoblastic, susceptibility to, 3 | NA | ORPHANET | Detail | |
| <0.001 | core binding factor acute myeloid leukemia | NA | BeFree | Detail | |
| 0.008 | Cytogenetically normal acute myeloid leukemia | Thus, identification of TET2 combined with classic NPM1 and FLT3-ITD mutations a... | BeFree | 24859829 | Detail |
| 0.002 | Alcoholic Intoxication, Chronic | NA | GAD | Detail | |
| <0.001 | Refractory anemias | NA | BeFree | Detail | |
| <0.001 | Refractory anaemia with excess blasts | NA | BeFree | Detail | |
| <0.001 | arthritis | NA | BeFree | Detail | |
| <0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
| <0.001 | Blast Phase | NA | BeFree | Detail | |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In this study, we show for the first time a significant accumulation of FLT3(+) CD11c(+) dendritic c... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In a Cox-model of predefined variables, age, FLT3-ITD and >1 course of chemotherapy to reach CR were... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In contrast, neither NUP98-NSD1 nor FLT3-ITD single transduced cells were able to initiate leukemia. | DisGeNET | Detail |
| Targeting FLT3 to treat leukemia. | DisGeNET | Detail |
| FLT3 was consequently upregulated in MLL-AF9-expressing immortalized and leukemia cells with a Hes1-... | DisGeNET | Detail |
| Targeting mitochondrial metabolism as an adjuvant therapy could therefore improve therapeutic respon... | DisGeNET | Detail |
| RNA interference against FLT3-ITD reduced cytotoxic effect and apoptosis induced by C-1311, indicati... | DisGeNET | Detail |
| The influence of genotypes on relapse, non-relapse mortality, leukemia-free survival (LFS) and overa... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our previous data demonstrated specific up-regulation of miR-155 in FLT3-ITD+ AML. miR-155 is known ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Internal tandem duplications (ITD) of FLT3 gene occur in about a third of acute promyelocytic leukem... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Some patient groups with unfavorable alterations, such as FMS-related tyrosine kinase 3-internal tan... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Oncogenic mutations of FLT3 and KIT receptors are associated with poor survival in patients with acu... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We herein report a case of AML accompanied by thoracic epidural MS with a high CD25 expression, the ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These findings show that targeted inhibition of FLT3, and hence direct interference with DCs, may be... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sun... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| FLT3/ITD is associated with poor outcomes in adult and pediatric acute myeloid leukemia (AML). | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We report the application of a new technique, tandem duplication PCR (TD-PCR), for detecting MRD in ... | DisGeNET | Detail |
| Although pretreatment covariates such as cytogenetics, monosomal karyotype, relapsed or refractory r... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We aimed to examine the consequences of targeting MYC both directly and indirectly in AML overexpres... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Among five patients diagnosed with MDS/MPN-U, three patients harboured RUNX1 (AML1) mutations; one c... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| JAK2(V617F) and FLT3(ITD)-positive polycythemia vera cells and acute myeloid leukemia cells also pro... | DisGeNET | Detail |
| JAK2(V617F) and FLT3(ITD)-positive polycythemia vera cells and acute myeloid leukemia cells also pro... | DisGeNET | Detail |
| At the time of MDS to CMML evolution, mutations in JAK2 (V617F), FLT3 (ITD), K-ras-2, or N-ras were ... | DisGeNET | Detail |
| Previous studies have reported FLT3 mutation in as many as 9.2% of myeloproliferative neoplasms (MPN... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Oncogenic mutations of FLT3 and KIT receptors are associated with poor survival in patients with acu... | DisGeNET | Detail |
| TP53 was the most common mutated gene in t-MDS (35.7%) as well as t-AML (33.3%), significantly highe... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We report the application of a new technique, tandem duplication PCR (TD-PCR), for detecting MRD in ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our previous data demonstrated specific up-regulation of miR-155 in FLT3-ITD+ AML. miR-155 is known ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We examined three pairs of monozygotic twins, two concordant and one discordant for hyperdiploid ALL... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our data confirm that dmCEBPA but not smCEBPA is prognostically favorable in NPM1(wt)FLT3-ITD(wt) AM... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Thus, identification of TET2 combined with classic NPM1 and FLT3-ITD mutations allowed us to stratif... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg19
- Position
- chr13:28,577,411-28,674,713
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- E588_Y589INSKYFYVDFRE
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/1631
Genome browser